These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25581609)

  • 1. The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.
    Hashimoto K; Kyoda Y; Tanaka T; Maeda T; Kobayashi K; Uchida K; Kitamura H; Hirata K; Tsukamoto T; Masumori N
    Lab Invest; 2015 Mar; 95(3):283-95. PubMed ID: 25581609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine androgen-independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
    Uchida K; Masumori N; Takahashi A; Itoh N; Kato K; Matusik RJ; Tsukamoto T
    Prostate; 2006 Apr; 66(5):536-45. PubMed ID: 16372327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
    Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
    Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
    Kim JT; Li J; Song J; Lee EY; Weiss HL; Townsend CM; Evers BM
    Oncotarget; 2015 Sep; 6(29):26960-70. PubMed ID: 26298774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
    Zheng C; Yinghao S; Li J
    Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
    He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
    Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
    Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for neurotensin in bicalutamide resistant prostate cancer cells.
    Vias M; Burtt G; Culig Z; Veerakumarasivam A; Neal DE; Mills IG
    Prostate; 2007 Feb; 67(2):190-202. PubMed ID: 17044078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME; Deeble PD; Lakhani S; Parsons SJ
    Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling.
    DaSilva JO; Amorino GP; Casarez EV; Pemberton B; Parsons SJ
    Prostate; 2013 Jun; 73(8):801-12. PubMed ID: 23192379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
    Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.
    Alifano M; Souazé F; Dupouy S; Camilleri-Broët S; Younes M; Ahmed-Zaïd SM; Takahashi T; Cancellieri A; Damiani S; Boaron M; Broët P; Miller LD; Gespach C; Regnard JF; Forgez P
    Clin Cancer Res; 2010 Sep; 16(17):4401-10. PubMed ID: 20810387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
    Amorino GP; Deeble PD; Parsons SJ
    Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
    Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
    Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelsolin Governs the Neuroendocrine Transdifferentiation of Prostate Cancer Cells and Suppresses the Apoptotic Machinery.
    Oelrich F; Junker H; Stope MB; Erb HHH; Walther R; Venz S; Zimmermann U
    Anticancer Res; 2021 Aug; 41(8):3717-3729. PubMed ID: 34281830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
    Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hypoxia induces androgen-independent and invasive behavior in LNCaP human prostate cancer cells.
    Yamasaki M; Nomura T; Sato F; Mimata H
    Urol Oncol; 2013 Oct; 31(7):1124-31. PubMed ID: 22226664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.